The Lung Cancer Screening Market is predicted to reach US$ by 2030 from US$ 2.65 billion in 2021, and to grow at a CAGR of 7.7% between the forecast period 2022 to 2030.
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2021. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
By Cancer Type (Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC)), by Test Type (Biopsy, Imaging and Biomarker Test), by End-user (Cancer Research Institute, Diagnostic Imaging Centers, Hospital Associated Labs, Independent Diagnostic Laboratories)
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
Qiagen N.V., Thermo Fisher Scientific Inc., Sanofi S.A., Agilent Technologies, Roche Diagnostics, and FUJIFILM Holdings Corporation, Medtronic plc, CANON MEDICAL SYSTEMS CORPORATION, Siemens Healthineers AG, and Koninklijke Philips N.V. among others
1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2020
2. Base Year - 2021
3. Forecasted Years - 2022 to 2030
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Lung Cancer Screening - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Lung Cancer Screening - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Lung Cancer Screening - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Lung Cancer Screening - ANALYSIS & FORECAST, BY REGION
North America Lung Cancer Screening
1. North America Lung Cancer Screening , by Country
1. US
2. Canada
1. North America Lung Cancer Screening , by Product
2. North America Lung Cancer Screening , by Type
3. North America Lung Cancer Screening , by Gender
4. North America Lung Cancer Screening , by Sales Channel
3. Europe Lung Cancer Screening
1. Europe Lung Cancer Screening , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Lung Cancer Screening , by Product
3. Europe Lung Cancer Screening , by Type
4. Europe Lung Cancer Screening , by Gender
5. Europe Lung Cancer Screening , by Sales Channel
4. Asia Pacific Lung Cancer Screening
1. Asia Pacific Lung Cancer Screening , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Lung Cancer Screening , by product
3. Asia Pacific Lung Cancer Screening , by Type
4. Asia Pacific Lung Cancer Screening , by Gender
5. Asia Pacific Lung Cancer Screening , by Sales Channel
5. Rest of the World Lung Cancer Screening
1. Rest of the World Lung Cancer Screening , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Lung Cancer Screening , by Product
3. Rest of the World Lung Cancer Screening , by Type
4. Rest of the World Lung Cancer Screening , by Gender
5. Rest of the World Lung Cancer Screening , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 62
The Protein Drug Screening Validation Database Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lan...
The AI-Driven Psychological Screening Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
Market Overview
The Asia Pacific Photodynamic Therapy Market is on the brink of significant growth, driven by increasing cancer prevalence, advancements in Photodynamic Therapy technology, and rising awareness about minimally invasive treatment options. Market research indicates a robus...
Market Overview
The Europe Photodynamic Therapy Market is poised for substantial growth in the coming decade, propelled by increasing cancer incidence, advancements in photodynamic therapy technology, and heightened awareness of minimally invasive treatments. Market research forecasts t...
Market Overview
The North America Photodynamic Therapy Market is projected to witness substantial growth in the coming decade, driven by the rising prevalence of cancer, advancements in Photodynamic Therapy technology, and increasing awareness of minimally invasive treatments. Market re...
Market Overview
The Global Photodynamic Therapy Market is poised to experience substantial growth in the coming decade, driven by the rising prevalence of cancer and other chronic diseases, advancements in PDT technology, and increasing awareness of minimally invasive treatment options....
The Diabetic Retinopathy Screening Solution Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...
The Employee Screening Tools Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactur...
The Nuclear Receptor Screening Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape,...
The Cancer-focused Genetic Testing Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsca...